Completed

NCT Number: NCT00944203

Efficacy of Ipomea Pes-caprae Ointment as an add-on Therapy in Patient With Jellyfish Dermatitis

This is an open label, prospective, test of superiority efficacy trial of Ipomea pes-caprae ointment as an add-on therapy in patient with jellyfish dermatitis. Each patient will receive standard medical treatment depend on the severity of the disease. The doctor will divide the dermatitis area of each patient into two parts. Ipomea pes-caprae ointment will be applied as an add-on therapy to the "test area", while the ointment will not be applied to the "control area". Patients will be asked to come for follow up 6 times in the 28-days study period. Primary objective is to compare the healing time of dermatitis in both areas.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Jellyfish Dermatitis Jellyfish Venoms

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Phase 2

Primary location

Hospital for Tropical Diseases, Faculty of Tropical Medicine, Mahidol University

Bangkok, 10400, Thailand

About this study

The "Test area" and "Control area" are allocated in each participant. We use the Internal Control fashion. The healing time of each area will be collected as an outcome measure.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

clinical diagnosis of jellyfish dermatitis
total lesion area is more than 4 square centimeter

Exclusion criteria

expose to jellyfish more than 7 days
severe systemic reaction to jellyfish
allergy to Ipomea pes-caprae or the component of the ointments

Treatment and study plan

Ipomea pes-caprae ointment

Drug

Ipomea pes-caprae ointment will be applied twice a day as an add-on therapy.

Primary outcomes

Healing time of the Jellyfish dermatitis lesion (days)

Time frame: Follow up to 28 days

Sponsors and collaborators

Lead sponsor

Mahidol University

Other

Registry information

Important dates

Study start: 2009
Primary completion: 2017
Study completion: 2017
First posted: Jul 23, 2009
Registry last updated: Mar 21, 2018

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.